KATHMANDU: NIBL Ace Capital has signed 'Roadmap for an IPO agreement' under its corporate advisory service with Alliance Pharmaceuticals.
The agreement was signed by Sachindra Dhungana Deputy General Manager of NIBL Ace Capital, and Manohar Das Mool, Chairman of Alliance Pharmaceuticals, in the presence of Sunil Pradhan, Managing Director of Alliance Pharmaceuticals, and Bhuwan Raj Panta, Head of Corporate Advisory Service of NIBL Ace Capital.
Alliance Pharmaceuticals operates under Company’s Act, 2063; having its Corporate Office at Kuleshwor, Kathmandu, and its manufacturing unit in Simara, Bara district. Alliance Pharmaceuticals is a company that has gained immense expertise in supplying and trading Medical products. The supplier company is located in Kathmandu and is one of the leading sellers of Medical products with the best quality products and services.
Alliance Pharmaceuticals is GMP certified pharmaceutical company from DDA.
According to the agreement, NIBL Ace Capital Limited will provide the company with pre-IPO and IPO services.
In the first phase, NIBL Ace Capital will provide consulting services to Alliance Pharmaceuticals in preparatory work to be done by the company before the issue of shares to the general public, on capital structure, issue process, size, pricing and assist in necessary document preparation required in the process of conversion of Private Limited Company to Public Limited company as a part of corporate advisory.
NIBL Ace Capital will also facilitate Alliance Pharmaceuticals in equity raising in Pre IPO stage. And in the second phase, it will work as the issue manager for the share to be issued to the general public. NIBL Ace Capital, under its Corporate Advisory Services, has been providing services like business plans, market assessment and feasibility, equity raising, and loan syndications to help develop business.
READ ALSO:
Published Date: April 29, 2023, 12:00 am
Post Comment
E-Magazine
Click Here To Read Full Issue
RELATED Uncategorized